Profound Medical has partnered with Siemens Healthineers to offer a complete solution for magnetic resonance imaging (MRI)-guided prostate therapy.
This agreement focuses on co-sales and co-marketing efforts for the new MRI-guided prostate therapy solution.
The solution combines Profound Medical’s TULSA-PRO system and consumables with Siemens Healthineers’ Magnetom Free.Max magnetic resonance (MR) scanner.
The partnership expands upon the non-exclusive collaboration announced in February this year, which also focused on the TULSA-PRO and Magnetom Free.Max technologies.
Canada-based Profound Medical develops and markets customisable, incision-free therapies for the ablation of diseased tissue.
The transurethral ultrasound ablation (TULSA) procedure, performed with Profound Medical’s TULSA-PRO system, offers precise MR-guided treatment for prostate disease. This procedure aims to preserve urinary continence and sexual function while targeting prostate tissue.
TULSA-PRO can ablate whole- or partial-gland prostate tissue in patients with low- to high-risk prostate cancer, benign prostatic hyperplasia (BPH), and those undergoing active surveillance.
According to Profound Medical, TULSA is capable of treating various prostate shapes and sizes with no bleeding, no hospital stays, and fast recovery for most patients.
Profound Medical CEO and Chairman Arun Menawat said: “Our definitive co-sales and co-marketing agreement with Siemens Healthineers aligns perfectly with our goal of ensuring that our technology can be readily accessed by urologists and their prostate disease patients in the widest possible range of treatment settings, especially now that CMS has recognised the value proposition of the TULSA procedure and placed it at Urology APC Level 7.”
Magnetom Free.Max is an MR scanner that features a 0.55 Tesla field strength with advanced hardware design and the proprietary deep learning image reconstruction technology, Deep Resolve.
It is said to be the first and only 80cm open bore MRI system on the market, making it ideal for MR scanning for larger or claustrophobic patients, thereby improving the patient experience.
The system’s compact design, weighing only 3.2 tonnes and standing under 2 meters tall, makes it the lightest superconducting MRI scanner ever offered by Siemens Healthineers.
With minimal helium requirements and no need for a quench pipe, it lowers lifecycle and infrastructure costs, making MRI more accessible in locations previously considered unsuitable for traditional MR imaging.
Siemens Healthineers magnetic resonance global marketing & sales head Donald Hardie said: “Magnetom Free.Max has already brought MR to new places, including orthopaedic centres, rural hospitals and Ambulatory Surgical Centres, where patients need diagnostic quality MR imaging most.”
Pending completion of the TULSA-PRO and Magnetom Free.Max compatibility process, and sales of the total prostate solution are expected to begin in 2025.
